Alcon AG vs Jones Lang LaSalle Inc — how do they compare? Alcon AG trades at $72.42 (market cap $36.44B), while Jones Lang LaSalle Inc trades at $361.02 (market cap $16.72B). The key difference: Alcon AG is far larger — about 2.2× Jones Lang LaSalle Inc's market cap, and Alcon AG pays a 0.48% dividend while Jones Lang LaSalle Inc pays none. Which is the better fit depends on your goals.
| ALC | JLL | |
|---|---|---|
Market Cap | $36.44B | $16.72B |
Sector | Health | Real Estate |
52-Week High | $90.12 | $373.24 |
52-Week Low | $62.02 | $280.16 |
Enterprise Value | $40.28B | $19.48B |
Dividend Yield | 0.48% | — |
Trailing returns across standard periods
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →